ImmuCell Corporation
ICCC
$6.20
-$0.05-0.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -65.31% | 181.19% | 173.34% | 54.19% | -249.76% |
| Total Depreciation and Amortization | -1.15% | 0.33% | -0.19% | 0.61% | 0.55% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 5.88% |
| Total Other Non-Cash Items | 8.90% | -40.87% | -19.45% | -46.60% | 71.85% |
| Change in Net Operating Assets | 169.05% | 53.10% | -86.00% | -148.93% | 903.33% |
| Cash from Operations | 1.76% | 50,867.74% | 99.52% | -209.88% | 39.02% |
| Capital Expenditure | 52.84% | -67.74% | -121.95% | 20.14% | -57.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 61.74% | -67.74% | -121.95% | 16.76% | -50.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.34% | -1.58% | -1.60% | -1.07% | -0.80% |
| Issuance of Common Stock | 1,600.52% | -97.62% | -77.24% | 757.35% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 42.09% | 85.26% | -- | 100.00% | -3,196.00% |
| Cash from Financing | 81.07% | -371.05% | -95.36% | 2,978.23% | 69.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 66.34% | 1,768.85% | -102.03% | 582.69% | 2,077.72% |